JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 16, Issue 1 (2024)
Iran J War Public Health 2024, 16(1): 61-65 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/10/31 | Accepted: 2024/03/4 | Published: 2024/03/25
Received: 2023/10/31 | Accepted: 2024/03/4 | Published: 2024/03/25
How to cite this article
Kazem S, Hussein M. Immunological Role of IL-17A and Biochemical Factors in Patients with Renal Failure Induced by Systemic Lupus Erythematosus. Iran J War Public Health 2024; 16 (1) :61-65
URL: http://ijwph.ir/article-1-1411-en.html
URL: http://ijwph.ir/article-1-1411-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
S.H. Kazem *1, M.H. Hussein1
1- Department of Pathological Analysis, College of Science, Thi-Qar University, Thi-Qar, Iraq
Abstract (781 Views)
Aims: The current investigation aimed to study the effect of certain parameters, including IL-17A, creatinine, lymphocytes, and basophils, on patients suffering from systemic lupus erythematosus-induced renal failure.
Materials & Methods: This clinically controlled study involved 105 patients (35 males, 70 females) confirmed to have systemic lupus erythematosus in Thi-Qar Province, Iraq. Researchers collected 5ml of venous blood from 50 healthy controls to conduct immune tests (to determine the levels of IL-17A by ELISA), biochemical tests (to measure creatinine levels by colorimetric method), and CBC tests (to assess lymphocyte and basophil counts). The data was analyzed using SPSS 23 software using the Chi-square and Welch's T-tests.
Findings: The systemic lupus erythematosus rate was 83%, and females exhibited a higher infection rate (66.7%) than males (33.3%). Significant differences between the sexes were identified. Also, significant increases were seen in the levels of IL-17A and creatinine in patients compared to healthy controls. Furthermore, females aged 13-45 were more affected than males. While levels of IL-17A and creatinine were elevated in some patients, lymphocyte and basophil levels were decreased in others compared to the healthy group.
Conclusion: IL-17A, creatinine, lymphocytes, and basophils play a fundamental role in the pathogenesis of systemic lupus erythematosus.
Materials & Methods: This clinically controlled study involved 105 patients (35 males, 70 females) confirmed to have systemic lupus erythematosus in Thi-Qar Province, Iraq. Researchers collected 5ml of venous blood from 50 healthy controls to conduct immune tests (to determine the levels of IL-17A by ELISA), biochemical tests (to measure creatinine levels by colorimetric method), and CBC tests (to assess lymphocyte and basophil counts). The data was analyzed using SPSS 23 software using the Chi-square and Welch's T-tests.
Findings: The systemic lupus erythematosus rate was 83%, and females exhibited a higher infection rate (66.7%) than males (33.3%). Significant differences between the sexes were identified. Also, significant increases were seen in the levels of IL-17A and creatinine in patients compared to healthy controls. Furthermore, females aged 13-45 were more affected than males. While levels of IL-17A and creatinine were elevated in some patients, lymphocyte and basophil levels were decreased in others compared to the healthy group.
Conclusion: IL-17A, creatinine, lymphocytes, and basophils play a fundamental role in the pathogenesis of systemic lupus erythematosus.
Keywords:
References
1. Justiz Vaillant AA, Goyal A, Varacallo M. Systemic lupus erythematosus. Treasure Island (FL): StatPearls Publishing; 2023. [Link]
2. Dema B, Charles N. Advances in mechanisms of systemic lupus erythematosus. Discov Med. 2014;17(95):247-55. [Link]
3. Bag-Ozbek A, Hui-Yuen JS. Emerging B-cell therapies in systemic lupus erythematosus. Ther Clin Risk Manag. 2021;17:39-54. [Link] [DOI:10.2147/TCRM.S252592]
4. Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14-25. [Link] [DOI:10.1136/annrheumdis-2020-218272]
5. Rovin BH, Ayoub I, Arora S. The clinical evaluation of kidney disease in systemic lupus erythematosus. In: Systemic lupus erythematosus. Cambridge: Academic Press; 2021. p. 379-88. [Link] [DOI:10.1016/B978-0-12-814551-7.00042-8]
6. Koga T, Ichinose K, Kawakami A, Tsokos GC. The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target. Expert Rev Clin Immunol. 2019;15(6):629-37. [Link] [DOI:10.1080/1744666X.2019.1593141]
7. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity. 2004;21(4):467-76. [Link] [DOI:10.1016/j.immuni.2004.08.018]
8. Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus. 2007;16(7):489-96. [Link] [DOI:10.1177/0961203307080226]
9. Burkett PR, Zu Horste GM, Kuchroo VK. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest. 2015;125(6):2211-9. [Link] [DOI:10.1172/JCI78085]
10. Hristova M, Kamenarska Z, Dzhebir G, Nikolova S, Hristova R, Mihova K, et al. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis. Rheumatol Int. 2021;41(12):2205-13. [Link] [DOI:10.1007/s00296-021-04996-z]
11. Tang Y, Tao H, Gong Y, Chen F, Li C, Yang X. Changes of serum IL-6, IL-17, and complements in systemic lupus erythematosus patients. Journal of Interferon & Cytokine Research. 2019;39(7):410-5. [Link] [DOI:10.1089/jir.2018.0169]
12. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3(1):1-54. [Link] [DOI:10.1016/0049-0172(73)90034-6]
13. Al-Rawi Z, Al-Shaarbaf H, Al-Raheem E, Khalifa SJ. Clinical features of early cases of systemic lupus erythematosus in Iraqi patients. Rheumatology. 1983;22(3):165-71. [Link] [DOI:10.1093/rheumatology/22.3.165]
14. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013;65(3):753-63. [Link] [DOI:10.1002/art.37795]
15. Taylor HG, Stein CM. Systemic lupus erythematosus in Zimbabwe. Ann Rheum Dis. 1986;45(8):645-8. [Link] [DOI:10.1136/ard.45.8.645]
16. Nasonov E, Soloviev S, Davidson JE, Lila A, Ivanova R, Togizbayev G, et al. The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine, and Kazakhstan). Lupus. 2014;23(2):213-9. [Link] [DOI:10.1177/0961203313512881]
17. Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: A comprehensive systematic analysis and modeling study. Ann Rheum Dis. 2023;82(3):351-6. [Link] [DOI:10.1136/ard-2022-223035]
18. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: A systematic review of epidemiological studies. Rheumatology. 2017;56(11):1945-61. [Link] [DOI:10.1093/rheumatology/kex260]
19. Osio-Salido E, Manapat-Reyes H. Epidemiology of systemic lupus erythematosus in Asia. Lupus. 2010;19(12):1365-73. [Link] [DOI:10.1177/0961203310374305]
20. Pradgan V, Patwardhan M, Rajadhyaksha A, Ghosh K. Clinical and immunological profile of systemic lupus erythematosus. Indian Pediatr. 2013;50(4):405-7. [Link] [DOI:10.1007/s13312-013-0115-z]
21. Abdulridha RH, Saud AM, Alosami MH. Evaluation of interferon-alpha (IFN-α) in women with systemic lupus erythematosus in Iraq. Iraqi J Sci. 2022;63(10):4225-33. [Link] [DOI:10.24996/ijs.2022.63.10.9]
22. Duarte-García A, Hocaoglu M, Valenzuela-Almada M, Osei-Onomah SA, Dabit JY, Sanchez-Rodriguez A, et al. Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades. Rheumat Dis. 2022;81(9):1260-6. [Link] [DOI:10.1136/annrheumdis-2022-222276]
23. Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25(14):1542-50. [Link] [DOI:10.1177/0961203316644333]
24. Sharifzadeh M, Naeimi S, Nasiri MM, Ariannia S, Farrokhseresht R. IL-17A gene polymorphism at position G197A and systemic lupus erythematosus. Rheumatol Res. 2018;3(3):107-12. [Link] [DOI:10.22631/rr.2018.69997.1050]
25. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine. 2005;84(4):218-24. [Link] [DOI:10.1097/01.md.0000170022.44998.d1]
26. McKiernan PJ, McElvaney NG, Greene CM. SLPI and inflammatory lung disease in females. Biochem Soc Trans. 2011;39(5):1421-6. [Link] [DOI:10.1042/BST0391421]
27. Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26(3):436-41. [Link]
28. AlSaleh J, Jassim V, ElSayed M, Saleh N, Harb D. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008;17(1):62-6. [Link] [DOI:10.1177/0961203307084297]
29. Wang WS, Chen PM, Hsiao HL, Wang HS, Liang WY, Su Y. Overexpression of the thymosin β-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene. 2004;23(39):6666-71. [Link] [DOI:10.1038/sj.onc.1207888]
30. Abdul-Razzaq LN, Jassim MMA, Mahmood MM. The high presence of HCMV pp71 proteins, correlate with P63 expression in pancreatic cancer tumor tissue. Asian Pac J Cancer Prev. 2023;24(4):1443-7. [Link] [DOI:10.31557/APJCP.2023.24.4.1443]
31. Chen M, Chen X, Wan Q. Altered frequency of Th17 and Treg cells in new‐onset systemic lupus erythematosus patients. Eur J Clin Invest. 2018;48(11):e13012. [Link] [DOI:10.1111/eci.13012]
32. Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF. Clinical associations of serum interleukin-17 in systemic lupus erythematosus. Arthrit Res Therap. 2013;15:R97. [Link] [DOI:10.1186/ar4277]
33. Wang Y, Ito S, Chino Y, Goto D, Matsumoto I, Murata H, et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol. 2010;159(1):1-10. [Link] [DOI:10.1111/j.1365-2249.2009.04031.x]
34. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus: Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum. 1989;32(7):826-36. [Link] [DOI:10.1002/j.2326-5205.1989.tb00013.x]
35. Ge J, Jin Z, Feng X, Pan W, Liu L, Wu M, et al. Creatinine clearance rate predicts prognosis of patients with systemic lupus erythematosus: a large retrospective cohort study. Clin Rheumatol. 2021;40:2221-31. [Link] [DOI:10.1007/s10067-020-05485-7]
36. Yang Z, Liang Y, Li C, Xi W, Zhong R. Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus. Rheumatol Int. 2012;32:2715-23. [Link] [DOI:10.1007/s00296-011-1987-7]
37. Hussein MH, Khalaf MM. Association of interleukin-6 and interleukin-1-β levels in patients with toxoplasmosis. Ann Parasitol. 2022;68(2):317-21. [Link]
38. Liang P, Tang Y, Fu S, Lv J, Liu B, Feng M, et al. Basophil count, a marker for disease activity in systemic lupus erythematosus. Clin Rheumatol. 2015;34(5):891-6. [Link] [DOI:10.1007/s10067-014-2822-9]
39. Pan Q, Gong L, Xiao H, Feng Y, Li L, Deng Z, et al. Basophil activation-dependent autoantibody and interleukin-17 production exacerbate systemic lupus erythematosus. Front Immunol. 2017;8:348. [Link] [DOI:10.3389/fimmu.2017.00348]
40. Rowlands DT, Daniele RP. Surface receptors in the immune response. N Engl J Med. 1975;293(1):26-32. [Link] [DOI:10.1056/NEJM197507032930108]
41. Rivero SJ, Díaz‐Jouanen E, Alarcón‐Segovia D. Lymphopenia in systemic lupus erythematosus. Arthritis Rheum. 1978;21(3):295-305. [Link] [DOI:10.1002/art.1780210302]
42. Dossybayeva K, Bexeitov Y, Mukusheva Z, Almukhamedova Z, Assylbekova M, Abdukhakimova D, et al. Analysis of peripheral blood basophils in pediatric systemic lupus erythematosus. Diagnostics. 2022;12(7):1701. [Link] [DOI:10.3390/diagnostics12071701]